{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T05:27:24Z","timestamp":1773638844535,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.placenta.2003.12.006","type":"journal-article","created":{"date-parts":[[2004,2,28]],"date-time":"2004-02-28T05:31:43Z","timestamp":1077946303000},"page":"642-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes"],"prefix":"10.1016","volume":"25","author":[{"given":"J.T.","family":"Van Horn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Craven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.W.","family":"Branch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2003.12.006_BIB1","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.placenta.2003.12.006_BIB3","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.placenta.2003.12.006_BIB4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0029-7844(95)00497-1","article-title":"Anticardiolipin antibodies: clinical consequences of \u201clow titers\u201d","volume":"87","author":"Silver","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0002-9378(16)32527-3","article-title":"Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant","volume":"142","author":"DeWolf","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0028-2243(91)90021-C","article-title":"Histo-pathological findings from patients with intrauterine fetal death and antiphospholipid antibodies","volume":"41","author":"Out","year":"1991","journal-title":"Eur J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJM198511213132104","article-title":"Obstetric complications associated with the lupus anticoagulant","volume":"313","author":"Branch","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.placenta.2003.12.006_BIB8","first-page":"150","article-title":"Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death","volume":"83","author":"Silver","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0046-8177(96)90377-9","article-title":"Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: a case report and review of the literature","volume":"27","author":"Nayar","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1471-0528.2002.00077.x","article-title":"Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome","volume":"109","author":"Sebire","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.placenta.2003.12.006_BIB11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJM198009183031204","article-title":"Decidual vasculopathy of the placenta in systemic lupus erythematosus","volume":"303","author":"Abramowsky","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.placenta.2003.12.006_BIB12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0002-9378(98)70277-7","article-title":"Placental pathology in systemic lupus erythematosus: a prospective study","volume":"179","author":"Magid","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0889-857X(05)70316-1","article-title":"Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome","volume":"23","author":"Salafia","year":"1997","journal-title":"Rheumat Dis Clin North Am"},{"key":"10.1016\/j.placenta.2003.12.006_BIB14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-2007-994176","article-title":"Placental pathology and antiphospholipid antibodies: a descriptive study","volume":"14","author":"Salafia","year":"1997","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9378(97)70559-3","article-title":"Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies","volume":"176","author":"Silver","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB16","first-page":"614","article-title":"Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience","volume":"80","author":"Branch","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00001721-199206000-00008","article-title":"The preparation of a partial thromboplastin reagent from bovine brain","volume":"3","author":"Martin","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.placenta.2003.12.006_BIB18","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ajcp\/94.4.476","article-title":"The second international anti-cardiolipin standardization workshop\/The Kingston anti-phospholipid antibody study (KAPS) group","volume":"94","author":"Harris","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB19","first-page":"672","article-title":"Fact and fancy. What can we really tell from the placenta?","volume":"115","author":"Macpherson","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.placenta.2003.12.006_BIB20","first-page":"204","article-title":"A conceptual approach to placental pathology and pregnancy outcome","volume":"10","author":"Altshuler","year":"1993","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB21","first-page":"131","article-title":"A study of sixty pregnancies in patients with the antiphospholipid syndrome","volume":"14","author":"Lima","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(11)90700-5","article-title":"Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB\/c mice: a model for autoimmune fetal loss","volume":"163","author":"Branch","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB23","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","article-title":"Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone to low-dose heparin treatment","volume":"166","author":"Cowchock","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.placenta.2003.12.006_BIB24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomized controlled trial of aspirin plus aspirin and heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.placenta.2003.12.006_BIB25","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400403003254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400403003254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:31:13Z","timestamp":1758907873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400403003254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0143400403003254"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2003.12.006","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2003.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}